Cancer, Ovarian Completed Phase 2 Trials for DB00569 (Fondaparinux)

Also known as: Cancer of the Ovary / Ovarian Cancer / Ovary Cancer / Cancer of Ovary / Ca ovary / Malignant tumor of ovary / Malignant neoplasm of ovary / Ovarian cancer NOS

IndicationStatusPhase
DBCOND0063542 (Cancer, Ovarian)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00381888Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic CancerTreatment